Universe Pharmaceuticals INC Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease)
Universe Pharmaceuticals INC (UPC) reported Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) of $3.41 million for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Notes › and Others
us-gaap:AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease · last filed 2026-01-29
| Period end | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 6 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month | Accounts Receivable, Allowance for Credit Loss, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | $3.41M 20-F · filed 2026-01-29 | ||
| 2024-09-30 | -$3.50M 20-F · filed 2026-01-29 | -$3.50K 20-F · filed 2025-04-29 | |
| 2024-03-31 | -$4.15K 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $5.19K 6-K · filed 2024-09-20 | ||
| 2022-09-30 | $74.05K 20-F · filed 2024-01-30 |